$214 Million is the total value of BOONE CAPITAL MANAGEMENT LLC's 12 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AMGN | New | AMGEN INC | $19,134,513 | – | 79,150 | +100.0% | 8.96% | – |
BAX | New | BAXTER INTL INC | $14,376,208 | – | 354,443 | +100.0% | 6.73% | – |
CERE | New | CEREVEL THERAPEUTICS HLDNG I | $7,317,000 | – | 300,000 | +100.0% | 3.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UNUM GROUP | 4 | Q3 2023 | 15.9% |
THE CIGNA GROUP | 4 | Q3 2023 | 12.3% |
MOLINA HEALTHCARE INC | 4 | Q3 2023 | 11.7% |
DANAHER CORPORATION | 4 | Q3 2023 | 10.4% |
ENOVIS CORPORATION | 4 | Q3 2023 | 9.8% |
BIOGEN INC | 4 | Q3 2023 | 7.8% |
QUANTERIX CORP | 4 | Q3 2023 | 4.9% |
AMGEN INC | 3 | Q3 2023 | 9.0% |
BAXTER INTL INC | 3 | Q3 2023 | 11.2% |
ABBVIE INC | 3 | Q2 2023 | 6.6% |
View BOONE CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
View BOONE CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.